Sonova Holding (OTCMKTS:SONVY) Short Interest Update
by Scott Moore · The Cerbat GemSonova Holding (OTCMKTS:SONVY – Get Free Report) was the target of a large increase in short interest in May. As of May 15th, there was short interest totaling 72,798 shares, an increase of 3,416.8% from the April 30th total of 2,070 shares. Based on an average daily volume of 84,663 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.0% of the company’s stock are short sold.
Analysts Set New Price Targets
SONVY has been the subject of a number of research reports. Jefferies Financial Group cut Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Finally, BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Sonova has an average rating of “Hold”.
Check Out Our Latest Stock Analysis on SONVY
Sonova Stock Performance
Shares of SONVY traded up $0.44 during mid-day trading on Wednesday, hitting $53.38. 21,770 shares of the company’s stock were exchanged, compared to its average volume of 42,539. Sonova has a 52 week low of $42.26 and a 52 week high of $63.69. The company has a 50-day simple moving average of $46.39 and a 200 day simple moving average of $49.92. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.
Sonova Company Profile
Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.